78 results found.
Sales Results for 20 Orthopaedic Companies: A Mid-year Status Report
By Julie A. Vetalice Now that we’ve collected 1H17 results from 20 publicly-traded companies, I’d like to share some performance-based observations. With now just 4 months remaining in the year, these companies provide a helpful gauge in projecting industry growth.
Orthofix Reports 2Q17 Revenue
Orthofix posted 2Q17 revenue of US $108.9MM, +4.7% from 2Q16, and 1H17 revenue of $211.7MM, +4.4% vs. 1H16.
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
Orthofix Reports 1Q17 Revenue
Orthofix posted 1Q17 revenue of US $102.7MM, +4.1% from 1Q16.
Orthofix Company Profile
We're redesigning Company Profiles. To get the most current news and articles about Orthofix in the interim, please...
Company Revenue 2016
For these publicly-traded orthopaedic device companies, Exhibits 1 and 2 present 2016 orthopaedic revenue and growth. Exhibit 1 includes links to company's full-year revenue reporting, as well. ...
Top 5 Orthopaedic Players Post Revenue Growth
Combined, the top five largest players in orthopaedics posted 2016 revenue of US $28.6BB, up $671.7MM or +2.4% vs. ...
Orthofix Reports 4Q16 and 2016 Revenue
Orthofix posted 2016 revenue of US $409.8MM, +3.4% from 2015, with 4Q16 revenue of $108.5MM, +3.7% vs. 4...
Globus Medical Preliminary 2016/4Q16 Revenue
Globus Medical announced preliminary unaudited 2016 sales of ~US $564.0MM, with 4Q16 sales of ~$151.6MM
Orthofix Reports Preliminary 2016/4Q16 Revenue
Orthofix announced preliminary 2016 sales of ~US $410.0MM, with 4Q16 sales of ~$109.0MM.
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
Orthofix Posts 3Q16 Revenue
Orthofix posted 3Q16 revenue of US $98.5MM, -2.6% from 3Q15.
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
Orthofix Posts 2Q16 Revenue
Orthofix posted 2Q16 revenue of US $104.1MM, +3.1% from 2Q15. (Trauma $26.8MM, +4.8%; Spine ...
Orthofix Posts 1Q16 Revenue
Orthofix posted 1Q16 revenue of US $98.7MM, +9.9% from 1Q15. (Trauma $24.7MM, +13.3%; Spine $18.8MM, +15.6%; Ortho...
Orthofix Reports 4Q15/2015 Revenue
Orthofix reported 4Q15 revenue of $104.6MM, +7.6% vs. 4Q14, and 2015 revenue of $396.5MM, +2.4% over 2014. Gr...
Company Revenue 2015: Orthofix
2015: $396.5MM, +2.4% CC 4Q15: $104.6MM, +7.6% CC ORTHOWORLD estimates 2015 segment revenue and as-reported growth as follows. Trauma $96.0MM, -12.4% Spine $75.6MM, -7.8% Orthobiologics $59.8MM, 7.1% Other $164.9MM, +6.6% (Bon...
Orthofix Reports Preliminary 4Q15 and 2015 Revenue
Orthofix announced preliminary unaudited 2015 sales of ~US $396MM, +2% from 2014, and 4Q15 revenue of
Orthofix 3Q15 Revenue +4% in CC
Orthofix posted 3Q15 revenue of US $101.1MM, +0.2% as reported / +4.1% CC, and YTD 2015 revenue of $291.8MM, -3.4%
BARE BONES® - August 4, 2015
Orthofix announced 2Q15 revenue of US $100.9MM, +5% from 2Q14. (BioStim $40.7MM, +3%; Biologics $15.2MM, +10%; Extremity Fixation $25.5MM, +12%; Spine Fixation $19.3MM, -4%) G...
BARE BONES® - May 18, 2015
Orthofix announced 1Q15 revenue of US $89.8MM, -7.4% from 1Q14. (BioStim $37.7MM, +2%; Biologics $13.9MM, +7%; Extremity Fixation $21.8MM, -9%; Spine Fixation $16.2MM, -28%) G...
BARE BONES® - April 29, 2015
Orthofix announced 4Q14 revenue of US $100.3MM, -3.4% from 4Q13, and 2014 revenue of $402.3MM, +1.2% from 2013. (2014 by segment: BioStim $154.6MM, +7%; Biologics $55.8MM, +4%...
BARE BONES® - March 31, 2015
Orthofix (OFIX) announced 3Q14 sales of US $101.0MM, +10% from 3Q13. (BioStim $38.3MM, +24.8%; Biologics $13.9MM, +5.3%; Extremity Fixation $27.6MM, +11.7%; Spine Fixation $21.2MM, -8....
BARE BONES® - March 24, 2015
Orthofix (OFIX) continues to work to complete procedures needed to file 2 delayed quarterly reports and amended restatements for prior periods, as well as its 2014 Form 10-K. OFIX will provide...
BARE BONES® - January 12, 2015
Orthofix expects to report 2013 revenue of US $397MM, and 2014 revenue in the range of $397MM to $401MM. (
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group